Organic compounds -- part of the class 532-570 series – Organic compounds – Nitrogen attached directly or indirectly to the purine ring...
Reexamination Certificate
2006-08-22
2006-08-22
McKenzie, Thomas C. (Department: 1624)
Organic compounds -- part of the class 532-570 series
Organic compounds
Nitrogen attached directly or indirectly to the purine ring...
C544S360000, C544S363000, C544S364000, C544S387000, C544S391000
Reexamination Certificate
active
07094895
ABSTRACT:
The present invention relates to compounds of the formulawherein R1and R2are independently hydrogen, C1–C4 alkyl, C1–C4 substituted alkyl, C1–C4 alkoxy, C1–C4 substituted alkoxy, C1–C4 acyl, halogen, cyano, nitro, amino, alkylamino, or dialkylamino;R3, R4, R5, R6, R7, and R8are independently CH or nitrogen;R9is hydrogen or methyl;R10is C═O or (CH2)n;where n is 0, 1, 2, 3, or 4;R11and R12are independently nitrogen or CH; X1and X2are independently hydrogen, deuterium, tritium or halogen; and X3is N; and their pharmaceutically acceptable salts; compositions thereof. Methods of preparing the compounds are also described. The compounds are useful in the treatment of diseases in mammals that are mediated by the action of the P2X7receptor.
REFERENCES:
patent: 5081246 (1992-01-01), Hidaka et al.
patent: 5244895 (1993-09-01), Hidaka et al.
patent: 2003/0232807 (2003-12-01), Poindexter et al.
patent: 513691 (1992-11-01), None
Williams, Michael et al, Ann Reports Med. Chem., vol. 31, 1996, pp. 21-30.
Fisher, Bilha, Exp. Opin. Ther. Patents, 9(4), 1999, pp. 385-399.
Acopyof the International Search Report mailed Jun. 6, 2003, issued in corresponding PCT Patent Application No.: PCT/US02/41385.
Gargett et al., 1997, “The Isoquinoline Derivative KN-62 a Potent Antagonist of the P2Z-Receptor of Human Lymphocytes”, British Journal of Pharmacology, 120, 1483-1490.
Hidaka et al., 1992, “Pharmacology of Protein Kinase Inhibitors”, Annu. Rev. Pharmacolo. Toxicol., 32:377-97.
Kawamura et al., 1996, “Cellular Events Involved in the Sensitization of Etopside-Resistant Cells by Inhibitors of Calcium-Calmodulin-Dependent Processes”, Biochemical Pharmacology, vol. 52, pp. 1903-1909.
Maurer et al., 1996, “Effects of Protein Kinase Inhibitors on Morphology and Function of Cultured Bovine Adrenal Chromaffin Cells: KN-62 Inhibits Secretory Function by Blocking Stimulated Ca2+Entry”, Journal of Neurochemistry, pp. 105-113.
Baraldi Pier Giovanni
Borea Pier A.
Jones Day
King Pharmaceuticals Research & Development, Inc.
McKenzie Thomas C.
LandOfFree
Tyrosyl derivatives and their use as P2X7 receptor modulators does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tyrosyl derivatives and their use as P2X7 receptor modulators, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tyrosyl derivatives and their use as P2X7 receptor modulators will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3644699